Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs
- 24 Juillet 2024 - 1 mn de lecture
This study will be conducted to support the registration of the lanreotide Autogel 120 mg formulation in China for the treatment of GEP-NETs and treatment of clinical symptoms of NETs. The study will include a screening period of up to 4 weeks followed by a 48-week intervention period. After completion of the main study period, approximately five participants will continue in a self/partner injection cohort with lanreotide Autogel 120 mg every 28 days for 24 weeks.
24 Juillet 2024
1 mn de lecture
A study to evaluate the effect of phenytoin or itraconazole on the circulating levels of IPN60130 in healthy adult participants
24 Juillet 2024
1 mn de lecture
A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ?14 Years With Fibrodysplasia Ossificans Progressiva...
24 Juillet 2024
1 mn de lecture
A study to assess whether adding maintenance cabozantinib (XL184) to best supportive care helps children, adolescents and young adults with osteosarcoma.
24 Juillet 2024
2 mn de lecture
A study to evaluate the effectiveness and safety of Dysport® for the prevention of episodic migraine in adults
24 Juillet 2024
2 mn de lecture
A study to evaluate the effectiveness and safety of Dysport® for the prevention of chronic migraine in adults
24 Juillet 2024
1 mn de lecture
A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.
24 Juillet 2024
2 mn de lecture
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
24 Juillet 2024
2 mn de lecture
Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours
24 Juillet 2024
1 mn de lecture
Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia
24 Juillet 2024
1 mn de lecture